Rentokil Initial plc (NYSE:RTO – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight analysts that are presently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $29.00.
A number of research firms recently commented on RTO. Citigroup upgraded Rentokil Initial to a “strong-buy” rating in a report on Friday, December 13th. Redburn Atlantic cut Rentokil Initial from a “buy” rating to a “neutral” rating in a research report on Thursday, September 19th.
Get Our Latest Report on Rentokil Initial
Institutional Investors Weigh In On Rentokil Initial
Rentokil Initial Stock Down 1.9 %
Rentokil Initial stock opened at $25.55 on Thursday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04. The company’s 50-day moving average is $25.53 and its 200-day moving average is $27.83. Rentokil Initial has a fifty-two week low of $22.40 and a fifty-two week high of $34.07.
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
See Also
- Five stocks we like better than Rentokil Initial
- There Are Different Types of Stock To Invest In
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- About the Markup Calculator
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.